AIG
CDTX

American International Group’s Cidara Therapeutics CDTX Stock Holding History

American International Group’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,050
Closed -$56 – 3139
2021
Q1 		$56 Buy
1,050
+3
+0.3% +$148 ﹤0.01% 2955
2020
Q4 		$42 Sell
1,047
-6
-0.6% -$298 ﹤0.01% 2995
2020
Q3 		$60K Buy
1,053
+32
+3% +$2.26K ﹤0.01% 2805
2020
Q2 		$75K Buy
+1,021
New +$66.2K ﹤0.01% 2698
2017
Q2 		– Sell
-334
Closed -$52K – 3084
2017
Q1 		$52K Buy
334
+26
+8% +$4.57K ﹤0.01% 2826
2016
Q4 		$64K Sell
308
-1
-0.3% -$208 ﹤0.01% 2793
2016
Q3 		$70.8K Hold
309
– – ﹤0.01% 2798
2016
Q2 		$63.7K Buy
309
+168
+119% +$40.7K ﹤0.01% 2874
2016
Q1 		$36K Hold
141
– – ﹤0.01% 4041
2015
Q4 		$48K Hold
141
– – ﹤0.01% 3928
2015
Q3 		$36K Hold
141
– – ﹤0.01% 4059
2015
Q2 		$39.6K Buy
+141
New +$43.4K ﹤0.01% 4143

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

American International Group's CDTX Position: Q2 2021 in Review

American International Group sold out of Cidara Therapeutics (CDTX) in Q2 2021, closing a stake of 1,050 shares — an estimated $56 sold.

American International Group first reported a position in CDTX in Q2 2015 and held it in 12 quarters. The position peaked at $75K in Q2 2020. 55 funds tracked by Wall St. Rank hold CDTX as of Q2 2021.

  • American International Group reported no remaining Cidara Therapeutics position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 1,050 Cidara Therapeutics shares in Q2 2021, an estimated $56.
  • American International Group first reported a position in Cidara Therapeutics in Q2 2015 and held it in 12 quarters.
  • American International Group's Cidara Therapeutics position peaked at $75K in Q2 2020.
  • 55 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.